Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
出版年份 2016 全文链接
标题
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
作者
关键词
-
出版物
PLoS One
Volume 11, Issue 9, Pages e0163069
出版商
Public Library of Science (PLoS)
发表日期
2016-09-21
DOI
10.1371/journal.pone.0163069
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A “systems medicine” approach to the study of non-alcoholic fatty liver disease
- (2016) Salvatore Petta et al. DIGESTIVE AND LIVER DISEASE
- MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease
- (2016) Salvatore Petta et al. JOURNAL OF HEPATOLOGY
- Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
- (2015) J. E. Hall et al. CIRCULATION RESEARCH
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
- (2015) Chiara Rosso et al. HEPATOLOGY
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease
- (2014) George B Goh et al. LIVER INTERNATIONAL
- Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease
- (2014) Lidija Orlic et al. WIENER KLINISCHE WOCHENSCHRIFT
- A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia
- (2014) Luca Valenti WORLD JOURNAL OF GASTROENTEROLOGY
- A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
- (2013) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- The role of angiotensin II in nonalcoholic steatohepatitis
- (2012) E. Matthew Morris et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia
- (2011) Mário Cláudio Soares Sturzeneker et al. ATHEROSCLEROSIS
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
- (2011) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
- (2008) Anna Ludovica Fracanzani et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started